image
Healthcare - Medical - Instruments & Supplies - NASDAQ - US
$ 72.5063
5.58 %
$ 14.5 B
Market Cap
34.39
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on Jun, 6, 2025.

The intrinsic value of one COO stock under the worst case scenario is HIDDEN Compared to the current market price of 72.5 USD, The Cooper Companies, Inc. is HIDDEN

This DCF valuation model was last updated on Jun, 6, 2025.

The intrinsic value of one COO stock under the base case scenario is HIDDEN Compared to the current market price of 72.5 USD, The Cooper Companies, Inc. is HIDDEN

This DCF valuation model was last updated on Jun, 6, 2025.

The intrinsic value of one COO stock under the best case scenario is HIDDEN Compared to the current market price of 72.5 USD, The Cooper Companies, Inc. is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart COO

image
$100.0$100.0$95.0$95.0$90.0$90.0$85.0$85.0$80.0$80.0$75.0$75.0$70.0$70.0$65.0$65.015 Dec15 DecJan '25Jan '2515 Jan15 JanFeb '25Feb '2515 Feb15 FebMar '25Mar '2515 Mar15 MarApr '25Apr '2515 Apr15 AprMay '25May '2515 May15 MayJun '25Jun '25
FINANCIALS
3.9 B REVENUE
8.41%
706 M OPERATING INCOME
32.38%
392 M NET INCOME
33.34%
709 M OPERATING CASH FLOW
16.76%
-765 M INVESTING CASH FLOW
-70.29%
39.2 M FINANCING CASH FLOW
122.54%
1 B REVENUE
3.90%
185 M OPERATING INCOME
1.54%
87.7 M NET INCOME
-15.92%
96.2 M OPERATING CASH FLOW
-49.53%
-79.2 M INVESTING CASH FLOW
18.18%
-8.6 M FINANCING CASH FLOW
91.10%
Balance Sheet The Cooper Companies, Inc.
image
Current Assets 1.95 B
Cash & Short-Term Investments 108 M
Receivables 717 M
Other Current Assets 1.13 B
Non-Current Assets 10.4 B
Long-Term Investments 0
PP&E 1.86 B
Other Non-Current Assets 8.5 B
5.82 %9.15 %15.13 %69.02 %Total Assets$12.3b
Current Liabilities 1.02 B
Accounts Payable 260 M
Short-Term Debt 33.3 M
Other Current Liabilities 729 M
Non-Current Liabilities 3.21 B
Long-Term Debt 2.55 B
Other Non-Current Liabilities 658 M
6.16 %17.23 %60.27 %15.56 %Total Liabilities$4.2b
EFFICIENCY
Earnings Waterfall The Cooper Companies, Inc.
image
Revenue 3.9 B
Cost Of Revenue 1.3 B
Gross Profit 2.6 B
Operating Expenses 1.89 B
Operating Income 706 M
Other Expenses 313 M
Net Income 392 M
4b4b4b4b3b3b3b3b2b2b2b2b1b1b500m500m004b(1b)3b(2b)706m(313m)392mRevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income
RATIOS
66.64% GROSS MARGIN
66.64%
18.12% OPERATING MARGIN
18.12%
10.07% NET MARGIN
10.07%
4.85% ROE
4.85%
3.19% ROA
3.19%
4.20% ROIC
4.20%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis The Cooper Companies, Inc.
image
600m600m500m500m400m400m300m300m200m200m100m100m0020162016201720172018201820192019202020202021202120222022202320232024202420252025
Net Income 392 M
Depreciation & Amortization 375 M
Capital Expenditures -421 M
Stock-Based Compensation 75.1 M
Change in Working Capital -334 M
Others -85 M
Free Cash Flow 288 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets The Cooper Companies, Inc.
image
Wall Street analysts predict an average 1-year price target for COO of $109 , with forecasts ranging from a low of $105 to a high of $115 .
COO Lowest Price Target Wall Street Target
105 USD 44.82%
COO Average Price Target Wall Street Target
109 USD 50.33%
COO Highest Price Target Wall Street Target
115 USD 58.61%
Price
Max Price Target
Min Price Target
Average Price Target
1151151101101051051001009595909085858080757570706565Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26Jun '26Jun '26
4. DIVIDEND ANALYSIS
0.00% DIVIDEND YIELD
0.0075 USD DIVIDEND PER SHARE
Q1
Q2
Q3
Q4
0.01600.01600.01400.01400.01200.01200.01000.01000.00800.00800.00600.00600.00400.00400.00200.00200.00000.00000.00750.00750.00750.00750.00750.00750.00750.00750.00750.00750.020.00750.020.00750.020.00750.020.00750.020.00750.020.00750.020.00750.020.00750.02201520152016201620172017201820182019201920202020202120212022202220232023
Download SVG
Download PNG
Download CSV
5. COMPETITION
slide 2 of 12
6. Ownership
Insider Ownership The Cooper Companies, Inc.
image
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
12.7 M USD 1
9-12 MONTHS
14.9 M USD 3
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
Why The Cooper Companies (COO) is a Top Growth Stock for the Long-Term Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service. zacks.com - 2 weeks ago
Understanding The Cooper Companies (COO) Reliance on International Revenue Explore The Cooper Companies' (COO) international revenue trends and how these numbers impact Wall Street's forecasts and what's ahead for the stock. zacks.com - 2 weeks ago
COO Q2 Earnings Signal Growth and Caution: How to Play the Stock? Cooper Companies COO delivered a solid fiscal second quarter performance in 2025, surpassing analyst expectations with $1 billion in revenue (up 6.3% YoY) and adjusted earnings per share (EPS) of 96 cents (up 14% YoY). Despite persistent macroeconomic headwinds and a slightly softened outlook for industry growth, management reaffirmed confidence in its core product momentum and operational leverage. zacks.com - 2 weeks ago
XRAY vs. COO: Which Stock Should Value Investors Buy Now? Investors looking for stocks in the Medical - Dental Supplies sector might want to consider either Dentsply International (XRAY) or The Cooper Companies (COO). But which of these two stocks offers value investors a better bang for their buck right now? zacks.com - 2 weeks ago
Top Stock Movers Now: Regeneron, Ulta Beauty, Cooper, and More U.S. equities were lower at midday as the market focused on the future of U.S.-China trade. The Dow Jones Industrial Average, S&P 500, and Nasdaq all lost ground. investopedia.com - 2 weeks ago
COO Q2 Earnings Beat, 2025 Sales Outlook Tightened, Stock Down COO's fiscal Q2 earnings and sales beat market expectations on the back of strong growth. Improvement in operating margin bodes well. zacks.com - 2 weeks ago
The Cooper Companies, Inc. (COO) Q2 2025 Earnings Call Transcript The Cooper Companies, Inc. (NASDAQ:COO ) Q2 2025 Results Conference Call May 29, 2025 5:00 PM ET Company Participants Kim Duncan - Vice President, Investor Relations & Risk Management Al White - President & Chief Executive Officer Brian Andrews - Chief Financial Officer & Treasurer Conference Call Participants Jeff Johnson - Baird Issie Kirby - Redburn Atlantic Larry Biegelsen - Wells Fargo Jon Block - Stifel Robbie Marcus - JPMorgan Craig Bijou - Bank of America Joanne Wuensch - Citi Young Li - Jefferies Chris Pasquale - Nephron Research Jason Badner - Piper Sandler Brett Fishbin - KeyBanc Steve Lichtman - Oppenheimer David Saxon - Needham & Company Navann Ty - BNP Paribas Operator Thank you for standing by. At this time, we would like to welcome you to the Q2 2025 Cooper Companies Earnings Conference Call. seekingalpha.com - 3 weeks ago
Cooper Companies raises 2025 profit forecast on contact lens demand Cooper Companies raised its annual profit forecast on Thursday, after beating quarterly results estimates, banking on strong demand for its contact lenses. reuters.com - 3 weeks ago
The Cooper Companies (COO) Reports Q2 Earnings: What Key Metrics Have to Say Although the revenue and EPS for The Cooper Companies (COO) give a sense of how its business performed in the quarter ended April 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers. zacks.com - 3 weeks ago
The Cooper Companies (COO) Surpasses Q2 Earnings and Revenue Estimates The Cooper Companies (COO) came out with quarterly earnings of $0.96 per share, beating the Zacks Consensus Estimate of $0.93 per share. This compares to earnings of $0.85 per share a year ago. zacks.com - 3 weeks ago
CooperCompanies Announces Second Quarter 2025 Results SAN RAMON, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, today announced financial results for its fiscal second quarter ended April 30, 2025. globenewswire.com - 3 weeks ago
Reasons to Retain The Cooper Companies Stock in Your Portfolio Now COO benefits from the strength in its business segments. Its acquisitions are likely to drive the top line. zacks.com - 3 weeks ago
8. Profile Summary

The Cooper Companies, Inc. COO

image
COUNTRY US
INDUSTRY Medical - Instruments & Supplies
MARKET CAP $ 14.5 B
Dividend Yield 0.00%
Description The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigues in the Americas, Europe, Middle East, Africa, and Asia Pacific. The CooperSurgical segment focuses on family and women's health care, which provides medical devices, fertility, genomics, diagnostics, and contraception to health care professionals and patients worldwide. It offers surgical and office products, including PARAGARD, uterine manipulators, retractors, closure products, point of care products, LEEP products, endosee, and illuminate and fetal pillows; fertility products and services, such as fertility consumables and equipment, and embryo options and preimplantation genetic testing. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.
Contact 6101 Bollinger Canyon Road, San Ramon, CA, 94583 https://www.coopercos.com
IPO Date Jan. 21, 1983
Employees 16000
Officers Mr. Gerard H. Warner III President of CooperVision, Inc. Ms. Holly R. Sheffield President of CooperSurgical, Inc. Mr. Kim Duncan Vice President of Investor Relations & Risk Management Mr. Nicholas S. Khadder J.D. Vice President, General Counsel & Corporate Secretary Mr. Albert G. White III President, Chief Executive Officer & Non-Independent Director Mr. Brian G. Andrews Executive Vice President, Chief Financial Officer & Treasurer Mr. Daniel G. McBride Esq. Executive Vice President & Chief Operating Officer Mr. Agostino Ricupati CPA Senior Vice President & Chief Accounting Officer